| Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and … F Lespérance, N Frasure-Smith, D Koszycki, MA Laliberté, LT van Zyl, ... Jama 297 (4), 367-379, 2007 | 868 | 2007 |
| Randomized trial of a meditation-based stress reduction program and cognitive behavior therapy in generalized social anxiety disorder D Koszycki, M Benger, J Shlik, J Bradwejn Behaviour Research and Therapy 45 (10), 2518-2526, 2007 | 509 | 2007 |
| Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder: clinical and behavioral findings J Bradwejn, D Koszycki, C Shriqui Archives of general psychiatry 48 (7), 603-610, 1991 | 411 | 1991 |
| Prenatal social support, postnatal social support, and postpartum depression RH Xie, G He, D Koszycki, M Walker, SW Wen Annals of epidemiology 19 (9), 637-643, 2009 | 347 | 2009 |
| Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder J Bradwejn, D Koszycki, G Meterissian The Canadian Journal of Psychiatry 35 (1), 83-85, 1990 | 327 | 1990 |
| Evaluation of anxiolytic properties of Gotukola–(Centella asiatica) extracts and asiaticoside in rat behavioral models P Wijeweera, JT Arnason, D Koszycki, Z Merali Phytomedicine 13 (9-10), 668-676, 2006 | 234 | 2006 |
| A multifaith spiritually based intervention for generalized anxiety disorder: A pilot randomized trial D Koszycki, K Raab, F Aldosary, J Bradwejn Journal of clinical psychology 66 (4), 430-441, 2010 | 219 | 2010 |
| A double-blind, placebo-controlled study on the effects of Gotu Kola (Centella asiatica) on acoustic startle response in healthy subjects J Bradwejn, Y Zhou, D Koszycki, J Shlik Journal of clinical psychopharmacology 20 (6), 680-684, 2000 | 209 | 2000 |
| The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder J Bradwejn, D Koszycki, AC du Tertre, H van Megen, J Den Boer, ... Archives of general psychiatry 51 (6), 486-493, 1994 | 204 | 1994 |
| Investigation of cholecystokinin system genes in panic disorder JL Kennedy, J Bradwejn, D Koszycki, N King, R Crowe, J Vincent, ... Molecular psychiatry 4 (3), 284-285, 1999 | 180 | 1999 |
| Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients. J Bradwejn, D Koszycki The American journal of psychiatry 151 (2), 261-263, 1994 | 145 | 1994 |
| What clinicians want: Findings from a psychotherapy practice research network survey. GA Tasca, J Sylvestre, L Balfour, L Chyurlia, J Evans, B Fortin-Langelier, ... Psychotherapy 52 (1), 1, 2015 | 137 | 2015 |
| Knowing when not to use the Internet: Shyness and adolescents’ on-line and off-line interactions with friends F Laghi, BH Schneider, I Vitoroulis, RJ Coplan, R Baiocco, ... Computers in Human Behavior 29 (1), 51-57, 2013 | 131 | 2013 |
| Association of the Val158Met catechol O-methyltransferase genetic polymorphism with panic disorder C Rothe, D Koszycki, J Bradwejn, N King, V Deluca, S Tharmalingam, ... Neuropsychopharmacology 31 (10), 2237-2242, 2006 | 125 | 2006 |
| The cholecystokinin hypothesis of anxiety and panic disorder J Bradwejn, D Koszycki Annals of the New York Academy of Sciences-Paper Edition 713, 273-282, 1994 | 125 | 1994 |
| Double-blind comparison of the effects of clonazepam and lorazepam in acute mania J Bradwejn, C SHRIQUI, D Koszycki, G Meterissian Journal of clinical psychopharmacology 10 (6), 403-408, 1990 | 120 | 1990 |
| Dose ranging study of the effects of cholecystokinin in healthy volunteers. J Bradwejn, D Koszycki, M Bourin Journal of Psychiatry and Neuroscience 16 (2), 91, 1991 | 107 | 1991 |
| Replication of action of cholecystokinin tetrapeptide in panic disorder: clinical and behavioral findings. J Bradwejn, D Koszycki, R Payeur, M Bourin, H Borthwick The American journal of psychiatry 149 (7), 962-964, 1992 | 103 | 1992 |
| Candidate genes in panic disorder: meta-analyses of 23 common variants in major anxiogenic pathways AS Howe, HN Buttenschøn, A Bani-Fatemi, E Maron, T Otowa, A Erhardt, ... Molecular psychiatry 21 (5), 665-679, 2016 | 101 | 2016 |
| Negative affect mediates the relationship between interpersonal problems and binge‐eating disorder symptoms and psychopathology in a clinical sample: A test of the … IV Ivanova, GA Tasca, N Hammond, L Balfour, K Ritchie, D Koszycki, ... European Eating Disorders Review 23 (2), 133-138, 2015 | 97 | 2015 |
